Search company, investor...

Bioengine

bio-engine.com.cn

Founded Year

2014

Stage

Series B - III | Alive

Total Raised

$31.39M

Last Raised

$31.39M | 10 mos ago

About Bioengine

Bioengine focuses on providing serum-free medium products and technical services for the biopharmaceutical industry such as antibodies, vaccines, and cell gene therapy.

Headquarters Location

5th Floor, Building 1, Cailun Road 720 Nong Pudong New District

Shanghai, Shanghai, 201203,

China

+86-21-68582660

Missing: Bioengine's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Bioengine's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Bioengine Frequently Asked Questions (FAQ)

  • When was Bioengine founded?

    Bioengine was founded in 2014.

  • Where is Bioengine's headquarters?

    Bioengine's headquarters is located at 5th Floor, Building 1, Cailun Road 720 Nong, Shanghai.

  • What is Bioengine's latest funding round?

    Bioengine's latest funding round is Series B - III.

  • How much did Bioengine raise?

    Bioengine raised a total of $31.39M.

  • Who are the investors of Bioengine?

    Investors of Bioengine include Hankang Equity Investment Management, Qingsong Capital, Legend Capital, Addor Capital, Wensong Tan and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.